Building a medtech brand?
We run PR and public affairs for companies in this market: from category launches and funding announcements to NHS procurement and regulatory communications.
BioSure
Self-test IVD manufacturer
Diagnostics & imagingPatient access & engagement
Essex-based manufacturer of CE-marked self-test IVDs, best known for producing the world's first CE-marked HIV self-test, sold through UK pharmacies and the NHS.
The read
BioSure develops and manufactures self-test in-vitro diagnostics, most notably the BioSure HIV Self Test, the first CE-marked HIV self-test on the market, alongside a wider range of self-test kits distributed through NHS sexual-health services and retail pharmacy.
Its distribution model, sold both online and through Boots UK stores, positions it toward consumer self-testing rather than lab-based diagnostics, giving it a more retail-facing route to patients than most diagnostics vendors in this index.
The Bridgehead view
BioSure's retail-pharmacy distribution through Boots is a genuinely different go-to-market from the NHS-procurement-led diagnostics story that dominates this sector, worth telling as a consumer-health narrative rather than a clinical-procurement one.
Work with us
Working across the healthcare sector?
We advise NHS-facing organisations, providers and health systems on reputation, policy engagement and communications that understand the sector.
Related platforms
Others in the sector map
Lateral-flow diagnostics manufacturer
SureScreen Diagnostics
Derby-based, family-run manufacturer of lateral-flow and rapid diagnostic test kits, an NHS supplier since 2010 that produced 20 million UK-manufactured rapid COVID-19 tests for the UK government.
ReadAt-home blood testing
Thriva
London at-home blood testing service that lets patients monitor cholesterol, hormones and other biomarkers via finger-prick kits, with results reviewed against partner-lab accreditation.
ReadBreath biopsy diagnostics
Owlstone Medical
Cambridge diagnostics company building breath-based tests, its Breath Biopsy platform, to detect cancer and other diseases from volatile organic compounds on a patient's breath.
ReadThe firm that knows medtech
We map this sector because
we represent it.
Whether you build medical technology or run the health systems that buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.
